Abstract. The present study investigated the metabolic effects of pulsatile insulin delivery at a pulse rate of 2+ 11 and 2+18 min in 7 healthy, elderly subjects (71.4\m=+-\2.1 years), submitted to 260 min controlled iv glucose infusion via the Biostator. The endogenous secretion of pancreatic hormones was inhibited by somatostatin (3 \g=m\g/min) and glucagon was replaced (67 ng/min) to basal levels. 
The same total insulin dose was delivered on both occasions. Insulin infusion rate was 1.3 and 2.0 mIU \m=.\ kg\m=-\1 \ m= . \ mi n\m=-\1 during switching on/off of 2+11 and 2+18 min, respectively. Blood glucose levels and glucose infusion rate were monitored continuously by the Biostator; [ D\ x=r eq-\ 3-3H]glucose infusion allowed determination of glucose turnover. During the last 60 min of the experiment, pulsatile insulin at a pulse rate of 2+11 vs 2+18 min produced a stronger inhibition of endogenous glucose production, whereas glucose disappearance rate and glucose metabolic clearance rate were similarly affected. Plasma triglycerides, apolipoprotein B, and free fatty acids levels were also more suppressed during insulin delivery at pulse rate of 2+11 than at 2+18 min.
Previous reports in animals and man have clearly demonstrated the existence of oscillations in pe¬ ripheral plasma insulin and glucagon levels (1) (2) (3) . It has been suggested that those oscillations depend on a pacemaker present in the gland itself. More¬ over, it has been shown that in normal healthy man, insulin oscillations have a periodicity of 13 min and a mean amplitude of 11.5 pmol/1 (1) (2) (3) . In noninsulin-dependent diabetic patients the oscillations of plasma insulin are more rapid and generally less regular than in normal subjects (4 (8) .
Calculations and statistical analysis
Rates of glucose turnover parameters were calculated from isotopic dilution data on 20-min integrated values using the classic monocompartmental model of Steele (9) . All other calculations were performed as previously re¬ ported (6 regularly, with a mean periodicity of 13 min and a mean amplitude of 11.5 pmol/1 (10) (11) (12) . In patients with non-insulin-dependent diabetes mellitus, the oscillations of plasma insulin are more rapid and generally less regular than in normal subjects (4 (14) may explain the stronger metabolic effects of pul¬ satile insulin delivery with a pulse rate of 2+11 min. These authors demonstrated that a B-cell pulse length of 2+ 11 min is absolutely necessary for al¬ lowing a rapid reduction and return of surface re¬ ceptor at the membrane level in the liver. Through the longer stay of insulin in the plasma compart¬ ment, a pulse rate of 2 +18 min may down-regulate the insulin receptor and impair insulin action.
As far as lipid metabolism is concerned, a longer pulse interval (2+18 min) of B-cell secretion may also derange lipid metabolism. In particular, inap¬ propriate plasma insulin oscillations may increase the production or decrease the clearance of very low-density lipoprotein. This hypothesis seems also supported by the observation that VLDL overpro¬ duction is linked to hyperinsulinism and that the correction of glucose homeostasis is associated with changes in plasma FFA, triglycérides, and VLDL triglycérides levels (15) .
In conclusion, the present study shows that a pul¬ satile insulin delivery rate of 2+18 min similar to the length of pulsatile B-cell secretion in the elderly (20 min), can contribute to impair glucose and lipid handling in the elderly.
